Search - tctmd.com

Displaying 781 - 800 of 922

Sort: Relevancy | Date

News Daily News

NCDR Study Documents US Radial PCI Gains

Yael L. Maxwell

June 20, 2013

News Daily News

由休克引起的死亡风险可能不会影响长期存活

L.A. McKeown

June 20, 2013

News Daily News

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

L.A. McKeown

June 20, 2013

News Daily News

El Mayor Riesgo de Mortalidad que acarrea el Shock podría No Afectar la Supervivencia a Largo Plazo

L.A. McKeown

June 20, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Caitlin E. Cox

May 24, 2013

Presentation

Heparin vs. Bivalirudin in Patients with NSTE-ACS Undergoing PCI

Presenter: Oskar Anger?s

May 23, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Daily News

Tras una PCI, una Rederivación Inmediata al Hospital Derivador es Segura para Pacientes víctimas de SCA

Leah Lawrence

April 26, 2013

News Daily News

After PCI, Immediate Retransfer to Referring Hospital Safe for ACS Patients

Leah Lawrence

April 26, 2013

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Industry News

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test

April 16, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Daily News

Post-acondicionamiento remoto reduce LRA en pacientes con NSTEMI

March 15, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

Presentation

SELECT-ACS: Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After PCI for NSTEMI

Presenter: Jean-Claude Tardif

March 12, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

News Daily News

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Caitlin E. Cox

March 09, 2013

Advertisement

NCDR Study Documents US Radial PCI Gains

由休克引起的死亡风险可能不会影响长期存活

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

El Mayor Riesgo de Mortalidad que acarrea el Shock podría No Afectar la Supervivencia a Largo Plazo

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Heparin vs. Bivalirudin in Patients with NSTE-ACS Undergoing PCI

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Tras una PCI, una Rederivación Inmediata al Hospital Derivador es Segura para Pacientes víctimas de SCA

After PCI, Immediate Retransfer to Referring Hospital Safe for ACS Patients

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test

Remote Postconditioning Reduces AKI in NSTEMI Patients

Post-acondicionamiento remoto reduce LRA en pacientes con NSTEMI

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

SELECT-ACS: Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After PCI for NSTEMI

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content